CAS: 3546-41-6; 2-(2-(2,5-Dimethyl-1-Phenyl-1H-Pyrrol-3-yl)Vinyl)-6-(Dimethylamino)-1-Methylquinolin-1-Ium Bis-4,4'-Methylenebis(3-Hydroxy-2-Naphthoate)

该化合物是一种合成化合物,主要用作一种抗肠寄生虫的止痛剂,对某些肠寄生虫有效,其特点是亮红色,通常以盐的形式出现,特别是一种可溶性和生物利用率提高的盐(或栓盐),其复合功能是抑制寄生虫的能量代谢,导致其最终死亡. 硫氨酸酯一般是口服的,在治疗剂量使用时,其对人类的毒性相对较低.其行动机制涉及干扰寄生虫利用葡萄糖的能力,这对它们的生存至关重要.此外,还研究了除寄生虫感染之外的潜在应用,包括它对某些癌症细胞的影响.但是,其使用主要侧重于治疗由海龟引起的感染.与任何药物一样,在开药或使用硫酸盐时,必须考虑潜在的副作用和反作用.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

(E)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)vinyl]-1-methyl-6-(dimethylamino)quinolinium methyl sulphate salt embonic acid disodium salt 4-amino-N,N-dimethylaniline (E)-2-(2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)vinyl)-6-(dimethylamino)-1-methylquinolin-1-ium iodide

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-7344863-B2
    优先权日:1998-03-13
    标题:Methods for producing polypeptides through enhanced synthesis of encoding nucleic acid molecules
    发明人:LI WU-BO; JESSEE JOEL A; SCHUSTER DAVID; XIA JIULIN; GEBEYEHU GULILAT
    权利人:INVITROGEN CORP
    摘要:The present invention is directed to compositions and methods for enhancing synthesis of nucleic acid molecules, particularly GC-rich nucleic acid molecules. Specifically, the invention provides compositions comprising one or more nitrogen-containing organic compounds having a formula selected from the group consisting of formula I and formula II (or salts or derivatives thereof), preferably 4-methylmorpholine N-oxide or betaine (carboxymethyltrimethylammonium), and further comprising one or more compounds selected from the group consisting of proline and an N-alkylimidazole compound, and more preferably proline, 1-methylimidazole or 4-methylimidazole. The invention further relates to methods for enhanced, high-fidelity synthesis of nucleic acid molecules, including via amplification (particularly PCR), reverse transcription, and sequencing methods. The invention also relates to nucleic acid molecules synthesized by these methods, to fragments or derivatives thereof, and to vectors and host cells comprising such nucleic acid molecules, fragments, or derivatives. The invention also relates to kits for synthesizing, amplifying, reverse transcribing or sequencing nucleic acid molecules comprising one or more of the compositions of the invention.

    专利号:WO-9824022-A1
    优先权日:1996-11-22
    标题:Method for incremental synthesis of a discrete technical system
    发明人:STEFFEN BERNHARD
    权利人:METAFRAME TECHNOLOGIES SOFTWAR; STEFFEN BERNHARD
    摘要:Disclosed is a method for knowledge-based incremental synthesis of a discrete technical system dependent upon a predetermined first configuration, wherein the first configuration represents an implemented consistent conflict-free causal structure. The first configuration comprises a predetermined knowledge base and a description of requirements controlling the synthesis, wherein a second configuration which fulfills the description of requirements is generated in the following steps: synthesis of a completed first intermediate causal structure that is not necessarily consistent or conflict-free, arising from the first configuration and the description of requirements by means of a fusion specification, and transformation of the first intermediate causal structure into a not necessarily conflict-free completed consistent second intermediate causal structure, and transformation of the completed second intermediate causal structure into a conflict-free consistent causal structure corresponding to the second configuration of the technical system by conflict resolution using conflict resolution conditions.

    专利号:US-7122304-B2
    优先权日:1997-05-12
    标 题:Methods for the storage and synthesis of nucleic acids using a solid support
    发明人:GOLDSBOROUGH MINDY D; FOX DONNA K
    权利人:WHATMAN INC
    摘要:The invention relates to storage of nucleic acid (particularly mRNA) on a solid support and to using such nucleic acid in nucleic acid synthesis or amplification reactions. In a preferred aspect, the invention provides synthesis of cDNA and cDNA libraries.

    专利号:US-2007178489-A1
    优先权日:1999-05-12
    标 题:Compositions and Methods for Enhanced Sensitivity and Specificity of Nucleic Acid Synthesis
    发明人:ASTATKE MEKBIB; CHATTERJEE DEB K; SHADILYA HARINI
    权利人:INVITROGEN CORP
    摘要:The present invention relates to polypeptides, compositions and methods for enhancing synthesis of nucleic acid molecules. In a preferred aspect, the invention relates to inhibition or control of nucleic acid synthesis, sequencing or amplification. Specifically, the present invention discloses polypeptides having affinity for double-stranded and/or single-stranded nucleic acid molecules and/or single-stranded/double-stranded nucleic acid complexes (e.g., primer/template complexes, double-stranded templates, single-stranded templates or single-stranded primers) for use in such enhanced synthesis and more particularly to polymerases having reduced polymerase and optionally reduced exonuclease activities (3′ to 5′ and/or 5′ to 3′ exonuclease activity), and to nucleases having reduced nuclease activity. The polypeptides of the invention are capable of inhibiting nonspecific nucleic acid synthesis at ambient temperature. Thus, in a preferred aspect, the invention relates to “hot startâ€? synthesis of nucleic acid molecules. Accordingly, the invention prevents non-specific nucleic acid synthesis at low temperatures, for example during reaction set up. The invention also relates to kits for synthesizing, amplifying, reverse transcribing or sequencing nucleic acid molecules comprising one or more of the polypeptides or compositions of the invention. The invention also relates to compositions prepared for carrying out the methods of the invention and to compositions made after or during such methods. The invention also generally relates to polypeptides and compositions useful for inhibiting or preventing degradation of various nucleic acid molecules.

    专利号:US-8043816-B2
    优先权日:1999-07-02
    标题 :Compositions and methods for temperature-dependent nucleic acid synthesis
    发明人:ASTATKE MEKBIB; CHATTERJEE DEB K; GERARD GARY F
    权利人:LIFE TECHNOLOGIES CORP
    摘要:The present invention relates to nucleic acid inhibitors, compositions and method for enhancing synthesis of nucleic acid molecules. In a preferred aspect, the invention relates to inhibition or control of nucleic acid synthesis, sequencing or amplification. Specifically, the present invention discloses nucleic acids having affinity for polypeptides with polymerase activity for use in such synthesis, amplification or sequencing reactions. The nucleic acid inhibitors are capable of inhibiting nonspecific nucleic acid synthesis under certain conditions (e.g., at ambient temperatures). Thus, in a preferred aspect, the invention relates to “hot startâ€? synthesis of nucleic acid molecules. Accordingly, the invention prevents, reduces or substantially reduces nonspecific nucleic acid synthesis. The invention also relates to kits for synthesizing, amplifying, reverse transcribing or sequencing nucleic acid molecules comprising one or more of the nucleic acid inhibitors or compositions of the invention. The invention also relates to using the inhibitors of the invention to prevent viral replication or treat viral infections in a subject. Thus, the invention relates to therapeutic methods and pharmaceutical compositions using the inhibitors of the invention. The invention thus may be used for in vivo and in vitro inhibition of nucleic acid synthesis and/or inhibition of polymerase acivity.

    专利号:US-2002037834-A1
    优先权日:2000-09-08
    标题 :Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
    发明人:ASTATKE MEKBIB; GEBEYEHU GULILAT
    权利人:INVITROGEN CORP
    摘要:The present invention relates to cationic and polycationic compositions and methods for enhancing synthesis of nucleic acid molecules. In a preferred aspect, the invention relates to inhibition or control of nucleic acid synthesis, sequencing or amplification. Specifically, the present invention discloses cationic and polycationic molecules, compounds, and compositions having affinity for double-stranded and/or single-stranded nucleic acid molecules and/or single-stranded/double-stranded nucleic acid complexes (e.g., primer/template complexes, double-stranded templates, single-stranded templates or single-stranded primers) for use in such enhanced synthesis. The cationic and polycationic molecules, compounds, and compositions of the invention are capable of inhibiting nonspecific nucleic acid synthesis at ambient temperature. Thus, in a preferred aspect, the invention relates to “hot startâ€? synthesis of nucleic acid molecules. Accordingly, the invention prevents non-specific nucleic acid synthesis at low temperatures, for example during reaction set up. The invention also relates to kits for synthesizing, amplifying, reverse transcribing or sequencing nucleic acid molecules comprising one or more of the cationic and polycationic molecules, compounds, and compositions of the invention. The invention also relates to compositions prepared for carrying out the methods of the invention and to compositions made after or during such methods. The invention also generally relates to compositions useful for inhibiting or preventing degradation of various nucleic acid molcules.
    上海澄拓化工科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.actchemical.com
    电话: 021-59904146 18001826933👤
    📞上海澄拓化工科技有限公司 ⚠️参考联系方式

    销售电话:021-59904146 18001826933
    邮箱:sales@actchemical.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州远大医药化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ydpharm.com
    企业联系电话:0519-88776993;83984084👤
    📞常州远大医药化工有限公司 ⚠️参考联系方式
    联系人:朱经理;袁经理
    电话:0519-88776993;83984084
    手机:13776846168;18118019798
    传真:0519-88776993
    邮箱:sales@ydpharm.com
    通信地址: 常州市新北区罗溪镇塑化路25号
    邮编: 213033
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:常州市新北区罗溪镇塑化路25号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Ghorbanalipoor S, Matsumoto K, Gross N, Heimberg L, Krause M, Veldkamp W, Magens M, Zanken J, Neuschutz KJ, De Luca DA, Kridin K, Vidarsson G, Chakievska L, Visser R, Kunzel S, Recke A, Gupta Y, Boch K, Vorobyev A, Kalies K, Manz RA, Bieber K, Ludwig RJ. High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses. J Autoimmun. 2024 Sep;148:103302. doi: 10.1016/j.jaut.2024.103302. Epub 2024 Aug 19.
    177:116991. doi: 10.1016/j.biopha.2024.116991. Epub 2024 Jun 21.
    3: Diaz D, Bergdorf K, Loberg MA, Phifer CJ, Xu GJ, Sheng Q, Chen SC, Byrant JM, Tigue ML, Hartmann H, Rohde SL, Netterville JL, Baregamian N, Goettel JA, Ye F, Lee E, Weiss VL. Wnt/β-catenin signaling is a therapeutic target in anaplastic thyroid carcinoma. Endocrine. 2024 May 28. doi: 10.1007/s12020-024-03887-0. Epub ahead of print.

    合成参考文献


    摘要:Arzneimittel-Forschung. Drug Research., 15(1349), 1965 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知